Cotrim and Otitis media - a phase IV clinical study of FDA data
Summary:
We study 15,361 people who take Cotrim (sulfamethoxazole; trimethoprim) or have Otitis media. No report of Otitis media is found in people who take Cotrim.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Cotrim?
Cotrim has active ingredients of sulfamethoxazole; trimethoprim. eHealthMe is studying from 8,890 Cotrim users. Check the latest studies of Cotrim.
What is Otitis Media?
Otitis media (inflammation of the middle ear) is found to be associated with 733 drugs and 653 conditions by eHealthMe. Check the latest studies of Otitis media.
No report is found.
Do you take Cotrim and have Otitis media?
- Check whether Otitis media is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cotrim:
- Cotrim (8,890 reports)
Otitis media treatments and more:
- Otitis media (6,471 reports)
How severe was Otitis media and when was it recovered:
Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:
Browse all side effects of Cotrim:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Otitis media:
Browse all the conditions that are associated with Otitis media:
How the study uses the data?
The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Cotrim) and Cotrim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lexapro and Gabapentin drug interactions for women aged 60+ - a second ago
- Leiomyosarcoma and Neutrophil Count Decreased - 2 seconds ago
- Benadryl and Muscle Spasms for Men aged 30-39 - 9 seconds ago
- Benadryl and Muscle Spasm for Men aged 30-39 - 10 seconds ago
- Pepcid and Neupogen drug interactions for men aged 50-59 - 11 seconds ago
- Could Gemcitabine cause Feeling Hot? - 17 seconds ago
- Rabeprazole Sodium vs. Zantac 75, side effect and effectiveness comparison - 19 seconds ago
- Could Dilantin cause Libido Decreased? - 24 seconds ago
- Could Bumex cause Blood Chloride Decreased? - 29 seconds ago
- Zolpidem Tartrate and Alcoholism for Men aged 40-49 - 34 seconds ago